Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | 2,3,4-Trihydroxybenzaldehyde | HCID 75064 | — |
| Reactant | (E)-3-(4-(hydrazinecarbonyl)phenyl)-N-hydroxyacrylamide | HCID 86669388 | — |
| Solvent | Dimethyl Sulfoxide | HCID 679 | — |
| Product | Pandacostat | HCID 135928012 | 23.3% |
Reaction Steps
Compound 6a was resynthesized and purified to be re-subjected to the biochemical assay to confirm the results from the initial library screen. To a 4 dram vial charged with 2,3,4-trihydroxybenzaldehyde (25.9 mg, 0.168 mmol) was added 420 μL of a 200 mM solution of hydrazine 5a (0.084 mmol) in DMSO. The solution was heated on a rotating heating block at 70° C. for 16 h. Reaction progress was monitored via LCMS. Following purification by reverse phase preparatory LCMS (44 mL/min, CH3CN/H2O with 1% formic acid, 5 min gradient), 6a (7 mg) was isolated as a yellow powder (98% pure, by analytical LCMS). 1H NMR (300 MHz, DMSO) δ 12.01 (s, 1H), 11.51 (s, 1H), 10.84 (s, 1H), 9.49 (s, 1H), 9.13 (s, 1H), 8.54 (s, 1H), 8.48 (s, 1H), 7.96 (d, J=8.3, 2H), 7.73 (d, J=8.2, 2H), 7.53 (d, J=16.2, 1H), 6.80 (d, J=8.6, 1H), 6.59 (d, J=15.9, 1H), 6.40 (d, J=8.4, 1H); m/z (ES−) 356 ([M-H]).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08716344B2 |
|---|
| Source dataset | uspto-grants-2014_05 |
|---|
| ORD ID | ord-36c1ba40bb754b12aef0398483c01933 |
|---|
| Source note | uspto-grants-2014_05 |
|---|